Wipar

Medicinal product

(Invented) name

Wipar

Active substance (s)

Paracetamolis/Pseudoefedrino hidrochloridas+Paracetamolis/Difenhidramino hidrochloridas

Strength

500 mg/60 mg + 500 mg/25 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Nereceptinis

Narrow therapeutic index (NTI)

ATC code (s)

R05X, Other cold preparations

Marketing authorisation holder

WICK Pharma, Vokietija

Date of authorisation

2018-07-30

Date of renewal

2023-01-31

Documents

Stage

Perregistruotas

Controlled?

Controlled substance type

Legal basis

10(1)

Procedure number

DE/H/5707/001

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Geltonos spalvos (dienos) tabletėje yra:	1 vnt.
Paracetamolis	500 mg
Pseudoefedrino hidrochloridas	60 mg
Mėlynos spalvos (nakties) tabletėje yra:	1 vnt.
Paracetamolis	500 mg
Difenhidramino hidrochloridas	25 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
99888	85996	1085996	lizdinė plokštelė	N16 (12 geltonų +4 mėlynos)		Nereceptinis	LT/1/18/4247/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2023-01-31	Perregistruotas
2018-07-30	Registruotas